The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor.
Takahashi S, Sakai J, Fujino T, Hattori H, Zenimaru Y, Suzuki J, Miyamori I, Yamamoto TT.
J Atheroscler Thromb. 2004;11(4):200-8. doi: 10.5551/jat.11.200.
Very low density lipoprotein apolipoprotein B metabolism in humans.
Demant T, Shepherd J, Packard CJ.
Klin Wochenschr. 1988 Aug 15;66(16):703-12. doi: 10.1007/BF01726412.
High-density lipoprotein turnover.
Nestel PJ.
Am Heart J. 1987 Feb;113(2 Pt 2):518-21. doi: 10.1016/0002-8703(87)90624-7.
Very low density and low density lipoprotein subfractions in type III and type IV hyperlipoproteinemia. Chemical and physical properties.
Packard CJ, Shepherd J, Joerns S, Gotto AM Jr, Taunton OD.
Biochim Biophys Acta. 1979 Feb 26;572(2):269-82. doi: 10.1016/0005-2760(79)90042-0.
Fish oil supplementation reduces beta-very low density lipoprotein in type III dysbetalipoproteinemia.
Dallongeville J, Boulet L, Davignon J, Lussier-Cacan S.
Arterioscler Thromb. 1991 Jul-Aug;11(4):864-71. doi: 10.1161/01.atv.11.4.864.
Familial hypertriglyceridemia/polygenic hypertrigliceridemia.
Lahoz C, Mostaza JM.
Clin Investig Arterioscler. 2021 May;33 Suppl 2:37-42. doi: 10.1016/j.arteri.2020.12.014.
Very low density lipoprotein metabolism in diabetes mellitus.
Ginsberg HN.
Diabetes Metab Rev. 1987 Apr;3(2):571-89. doi: 10.1002/dmr.5610030209.
Why very low density lipoprotein levels are normal in familial hyperchylomicronaemia.
Berger GM.
Atherosclerosis. 1979 Sep;34(1):83-6. doi: 10.1016/0021-9150(79)90109-6.
Low density lipoprotein metabolism in type IV and type V hyperlipoproteinemia.
Brook JG, Torsvik H, Lees RS, McCluskey MA, Feldman HA.
Metabolism. 1979 Jan;28(1):4-8. doi: 10.1016/0026-0495(79)90161-6.
Chylomicron and very-low-density lipoprotein levels in type I hyperlipoproteinaemia. The role of the liver in determining biochemical phenotype.
Berger GM, Van der Westhuyzen JH, Huskisson J, Bonnici F, Henderson HE.
S Afr Med J. 1982 Feb 20;61(8):266-72.
